{"id":"https://openalex.org/W1978346382","doi":"https://doi.org/10.1161/01.str.30.3.508","title":"Dose Escalation Study of the NMDA Glycine-Site Antagonist Licostinel in Acute Ischemic Stroke","display_name":"Dose Escalation Study of the NMDA Glycine-Site Antagonist Licostinel in Acute Ischemic Stroke","publication_year":1999,"publication_date":"1999-03-01","ids":{"openalex":"https://openalex.org/W1978346382","doi":"https://doi.org/10.1161/01.str.30.3.508","mag":"1978346382","pmid":"https://pubmed.ncbi.nlm.nih.gov/10066844"},"language":"en","primary_location":{"id":"doi:10.1161/01.str.30.3.508","doi":"https://doi.org/10.1161/01.str.30.3.508","is_oa":false,"landing_page_url":"https://doi.org/10.1161/01.str.30.3.508","pdf_url":null,"source":{"id":"https://openalex.org/S62532593","display_name":"Stroke","issn_l":"0039-2499","issn":["0039-2499","1524-4628"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Stroke","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024460519","display_name":"Gregory W. Albers","orcid":"https://orcid.org/0000-0003-0263-4632","observed_orcids":["https://orcid.org/0000-0003-0263-4632"]},"institutions":[{"id":"https://openalex.org/I1315135799","display_name":"Marshfield Clinic","ror":"https://ror.org/025chrz76","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315135799"]},{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I2801620527","display_name":"Mercy General Hospital","ror":"https://ror.org/04bt00m07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801620527","https://openalex.org/I2802827176"]},{"id":"https://openalex.org/I4210132091","display_name":"Electron Energy Corporation (United States)","ror":"https://ror.org/03v1rmf39","country_code":"US","type":"company","lineage":["https://openalex.org/I4210132091"]},{"id":"https://openalex.org/I4210138321","display_name":"Marshfield Clinic","ror":"https://ror.org/03zxy2q77","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210138321"]},{"id":"https://openalex.org/I4210158797","display_name":"CEP America","ror":"https://ror.org/04sygbn06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210158797"]},{"id":"https://openalex.org/I4405267392","display_name":"Kyverna Therapeutics, Inc. (United States)","ror":"https://ror.org/02jkbkr44","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267392"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory W. Albers","raw_affiliation_strings":["From the Stanford Stroke Center, Palo Alto, Calif (G.W.A.); Oregon Health Sciences University, Portland, Ore (W.M.C); Mercy General Hospital, Sacramento, Calif (R.P.A.); Marshfield Clinic, Marchfield, Wis (K.M.); CoCensys, Irvine, Calif (J.L.D.); and Chiron Corporation, Emeryville, Calif (M.J.W.)","Chiron Corporation, Emeryville, Calif (M.J.W.)","CoCensys, Irvine, Calif (J.L.D.)","Marshfield Clinic, Marchfield, Wis (K.M.)","Mercy General Hospital, Sacramento, Calif (R.P.A.)","Oregon Health Sciences University, Portland, Ore (W.M.C)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Stanford Stroke Center, Palo Alto, Calif (G.W.A.); Oregon Health Sciences University, Portland, Ore (W.M.C); Mercy General Hospital, Sacramento, Calif (R.P.A.); Marshfield Clinic, Marchfield, Wis (K.M.); CoCensys, Irvine, Calif (J.L.D.); and Chiron Corporation, Emeryville, Calif (M.J.W.)","institution_ids":["https://openalex.org/I1315135799","https://openalex.org/I165690674","https://openalex.org/I2801620527","https://openalex.org/I4210138321"]},{"raw_affiliation_string":"Chiron Corporation, Emeryville, Calif (M.J.W.)","institution_ids":["https://openalex.org/I4210132091","https://openalex.org/I4210158797","https://openalex.org/I4405267392"]},{"raw_affiliation_string":"CoCensys, Irvine, Calif (J.L.D.)","institution_ids":[]},{"raw_affiliation_string":"Marshfield Clinic, Marchfield, Wis (K.M.)","institution_ids":["https://openalex.org/I1315135799"]},{"raw_affiliation_string":"Mercy General Hospital, Sacramento, Calif (R.P.A.)","institution_ids":["https://openalex.org/I2801620527"]},{"raw_affiliation_string":"Oregon Health Sciences University, Portland, Ore (W.M.C)","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003394099","display_name":"Wayne M. Clark","orcid":"https://orcid.org/0000-0001-7901-5659","observed_orcids":["https://orcid.org/0000-0001-7901-5659"]},"institutions":[{"id":"https://openalex.org/I1315135799","display_name":"Marshfield Clinic","ror":"https://ror.org/025chrz76","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315135799"]},{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I2801620527","display_name":"Mercy General Hospital","ror":"https://ror.org/04bt00m07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801620527","https://openalex.org/I2802827176"]},{"id":"https://openalex.org/I4210132091","display_name":"Electron Energy Corporation (United States)","ror":"https://ror.org/03v1rmf39","country_code":"US","type":"company","lineage":["https://openalex.org/I4210132091"]},{"id":"https://openalex.org/I4210138321","display_name":"Marshfield Clinic","ror":"https://ror.org/03zxy2q77","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210138321"]},{"id":"https://openalex.org/I4210158797","display_name":"CEP America","ror":"https://ror.org/04sygbn06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210158797"]},{"id":"https://openalex.org/I4405267392","display_name":"Kyverna Therapeutics, Inc. (United States)","ror":"https://ror.org/02jkbkr44","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267392"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wayne M. Clark","raw_affiliation_strings":["From the Stanford Stroke Center, Palo Alto, Calif (G.W.A.); Oregon Health Sciences University, Portland, Ore (W.M.C); Mercy General Hospital, Sacramento, Calif (R.P.A.); Marshfield Clinic, Marchfield, Wis (K.M.); CoCensys, Irvine, Calif (J.L.D.); and Chiron Corporation, Emeryville, Calif (M.J.W.)","Chiron Corporation, Emeryville, Calif (M.J.W.)","CoCensys, Irvine, Calif (J.L.D.)","Marshfield Clinic, Marchfield, Wis (K.M.)","Mercy General Hospital, Sacramento, Calif (R.P.A.)","Oregon Health Sciences University, Portland, Ore (W.M.C)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Stanford Stroke Center, Palo Alto, Calif (G.W.A.); Oregon Health Sciences University, Portland, Ore (W.M.C); Mercy General Hospital, Sacramento, Calif (R.P.A.); Marshfield Clinic, Marchfield, Wis (K.M.); CoCensys, Irvine, Calif (J.L.D.); and Chiron Corporation, Emeryville, Calif (M.J.W.)","institution_ids":["https://openalex.org/I1315135799","https://openalex.org/I165690674","https://openalex.org/I2801620527","https://openalex.org/I4210138321"]},{"raw_affiliation_string":"Chiron Corporation, Emeryville, Calif (M.J.W.)","institution_ids":["https://openalex.org/I4210132091","https://openalex.org/I4210158797","https://openalex.org/I4405267392"]},{"raw_affiliation_string":"CoCensys, Irvine, Calif (J.L.D.)","institution_ids":[]},{"raw_affiliation_string":"Marshfield Clinic, Marchfield, Wis (K.M.)","institution_ids":["https://openalex.org/I1315135799"]},{"raw_affiliation_string":"Mercy General Hospital, Sacramento, Calif (R.P.A.)","institution_ids":["https://openalex.org/I2801620527"]},{"raw_affiliation_string":"Oregon Health Sciences University, Portland, Ore (W.M.C)","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108102469","display_name":"Richard Presley Atkinson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1315135799","display_name":"Marshfield Clinic","ror":"https://ror.org/025chrz76","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315135799"]},{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I2801620527","display_name":"Mercy General Hospital","ror":"https://ror.org/04bt00m07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801620527","https://openalex.org/I2802827176"]},{"id":"https://openalex.org/I4210132091","display_name":"Electron Energy Corporation (United States)","ror":"https://ror.org/03v1rmf39","country_code":"US","type":"company","lineage":["https://openalex.org/I4210132091"]},{"id":"https://openalex.org/I4210138321","display_name":"Marshfield Clinic","ror":"https://ror.org/03zxy2q77","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210138321"]},{"id":"https://openalex.org/I4210158797","display_name":"CEP America","ror":"https://ror.org/04sygbn06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210158797"]},{"id":"https://openalex.org/I4405267392","display_name":"Kyverna Therapeutics, Inc. (United States)","ror":"https://ror.org/02jkbkr44","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267392"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard P. Atkinson","raw_affiliation_strings":["From the Stanford Stroke Center, Palo Alto, Calif (G.W.A.); Oregon Health Sciences University, Portland, Ore (W.M.C); Mercy General Hospital, Sacramento, Calif (R.P.A.); Marshfield Clinic, Marchfield, Wis (K.M.); CoCensys, Irvine, Calif (J.L.D.); and Chiron Corporation, Emeryville, Calif (M.J.W.)","Chiron Corporation, Emeryville, Calif (M.J.W.)","CoCensys, Irvine, Calif (J.L.D.)","Marshfield Clinic, Marchfield, Wis (K.M.)","Mercy General Hospital, Sacramento, Calif (R.P.A.)","Oregon Health Sciences University, Portland, Ore (W.M.C)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Stanford Stroke Center, Palo Alto, Calif (G.W.A.); Oregon Health Sciences University, Portland, Ore (W.M.C); Mercy General Hospital, Sacramento, Calif (R.P.A.); Marshfield Clinic, Marchfield, Wis (K.M.); CoCensys, Irvine, Calif (J.L.D.); and Chiron Corporation, Emeryville, Calif (M.J.W.)","institution_ids":["https://openalex.org/I1315135799","https://openalex.org/I165690674","https://openalex.org/I2801620527","https://openalex.org/I4210138321"]},{"raw_affiliation_string":"Chiron Corporation, Emeryville, Calif (M.J.W.)","institution_ids":["https://openalex.org/I4210132091","https://openalex.org/I4210158797","https://openalex.org/I4405267392"]},{"raw_affiliation_string":"CoCensys, Irvine, Calif (J.L.D.)","institution_ids":[]},{"raw_affiliation_string":"Marshfield Clinic, Marchfield, Wis (K.M.)","institution_ids":["https://openalex.org/I1315135799"]},{"raw_affiliation_string":"Mercy General Hospital, Sacramento, Calif (R.P.A.)","institution_ids":["https://openalex.org/I2801620527"]},{"raw_affiliation_string":"Oregon Health Sciences University, Portland, Ore (W.M.C)","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109946418","display_name":"Kenneth P. Madden","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1315135799","display_name":"Marshfield Clinic","ror":"https://ror.org/025chrz76","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315135799"]},{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I2801620527","display_name":"Mercy General Hospital","ror":"https://ror.org/04bt00m07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801620527","https://openalex.org/I2802827176"]},{"id":"https://openalex.org/I4210132091","display_name":"Electron Energy Corporation (United States)","ror":"https://ror.org/03v1rmf39","country_code":"US","type":"company","lineage":["https://openalex.org/I4210132091"]},{"id":"https://openalex.org/I4210138321","display_name":"Marshfield Clinic","ror":"https://ror.org/03zxy2q77","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210138321"]},{"id":"https://openalex.org/I4210158797","display_name":"CEP America","ror":"https://ror.org/04sygbn06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210158797"]},{"id":"https://openalex.org/I4405267392","display_name":"Kyverna Therapeutics, Inc. (United States)","ror":"https://ror.org/02jkbkr44","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267392"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth Madden","raw_affiliation_strings":["From the Stanford Stroke Center, Palo Alto, Calif (G.W.A.); Oregon Health Sciences University, Portland, Ore (W.M.C); Mercy General Hospital, Sacramento, Calif (R.P.A.); Marshfield Clinic, Marchfield, Wis (K.M.); CoCensys, Irvine, Calif (J.L.D.); and Chiron Corporation, Emeryville, Calif (M.J.W.)","Chiron Corporation, Emeryville, Calif (M.J.W.)","CoCensys, Irvine, Calif (J.L.D.)","Marshfield Clinic, Marchfield, Wis (K.M.)","Mercy General Hospital, Sacramento, Calif (R.P.A.)","Oregon Health Sciences University, Portland, Ore (W.M.C)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Stanford Stroke Center, Palo Alto, Calif (G.W.A.); Oregon Health Sciences University, Portland, Ore (W.M.C); Mercy General Hospital, Sacramento, Calif (R.P.A.); Marshfield Clinic, Marchfield, Wis (K.M.); CoCensys, Irvine, Calif (J.L.D.); and Chiron Corporation, Emeryville, Calif (M.J.W.)","institution_ids":["https://openalex.org/I1315135799","https://openalex.org/I165690674","https://openalex.org/I2801620527","https://openalex.org/I4210138321"]},{"raw_affiliation_string":"Chiron Corporation, Emeryville, Calif (M.J.W.)","institution_ids":["https://openalex.org/I4210132091","https://openalex.org/I4210158797","https://openalex.org/I4405267392"]},{"raw_affiliation_string":"CoCensys, Irvine, Calif (J.L.D.)","institution_ids":[]},{"raw_affiliation_string":"Marshfield Clinic, Marchfield, Wis (K.M.)","institution_ids":["https://openalex.org/I1315135799"]},{"raw_affiliation_string":"Mercy General Hospital, Sacramento, Calif (R.P.A.)","institution_ids":["https://openalex.org/I2801620527"]},{"raw_affiliation_string":"Oregon Health Sciences University, Portland, Ore (W.M.C)","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036345645","display_name":"Joann L. Data","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1315135799","display_name":"Marshfield Clinic","ror":"https://ror.org/025chrz76","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315135799"]},{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I2801620527","display_name":"Mercy General Hospital","ror":"https://ror.org/04bt00m07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801620527","https://openalex.org/I2802827176"]},{"id":"https://openalex.org/I4210132091","display_name":"Electron Energy Corporation (United States)","ror":"https://ror.org/03v1rmf39","country_code":"US","type":"company","lineage":["https://openalex.org/I4210132091"]},{"id":"https://openalex.org/I4210138321","display_name":"Marshfield Clinic","ror":"https://ror.org/03zxy2q77","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210138321"]},{"id":"https://openalex.org/I4210158797","display_name":"CEP America","ror":"https://ror.org/04sygbn06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210158797"]},{"id":"https://openalex.org/I4405267392","display_name":"Kyverna Therapeutics, Inc. (United States)","ror":"https://ror.org/02jkbkr44","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267392"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joann L. Data","raw_affiliation_strings":["From the Stanford Stroke Center, Palo Alto, Calif (G.W.A.); Oregon Health Sciences University, Portland, Ore (W.M.C); Mercy General Hospital, Sacramento, Calif (R.P.A.); Marshfield Clinic, Marchfield, Wis (K.M.); CoCensys, Irvine, Calif (J.L.D.); and Chiron Corporation, Emeryville, Calif (M.J.W.)","Chiron Corporation, Emeryville, Calif (M.J.W.)","CoCensys, Irvine, Calif (J.L.D.)","Marshfield Clinic, Marchfield, Wis (K.M.)","Mercy General Hospital, Sacramento, Calif (R.P.A.)","Oregon Health Sciences University, Portland, Ore (W.M.C)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Stanford Stroke Center, Palo Alto, Calif (G.W.A.); Oregon Health Sciences University, Portland, Ore (W.M.C); Mercy General Hospital, Sacramento, Calif (R.P.A.); Marshfield Clinic, Marchfield, Wis (K.M.); CoCensys, Irvine, Calif (J.L.D.); and Chiron Corporation, Emeryville, Calif (M.J.W.)","institution_ids":["https://openalex.org/I1315135799","https://openalex.org/I165690674","https://openalex.org/I2801620527","https://openalex.org/I4210138321"]},{"raw_affiliation_string":"Chiron Corporation, Emeryville, Calif (M.J.W.)","institution_ids":["https://openalex.org/I4210132091","https://openalex.org/I4210158797","https://openalex.org/I4405267392"]},{"raw_affiliation_string":"CoCensys, Irvine, Calif (J.L.D.)","institution_ids":[]},{"raw_affiliation_string":"Marshfield Clinic, Marchfield, Wis (K.M.)","institution_ids":["https://openalex.org/I1315135799"]},{"raw_affiliation_string":"Mercy General Hospital, Sacramento, Calif (R.P.A.)","institution_ids":["https://openalex.org/I2801620527"]},{"raw_affiliation_string":"Oregon Health Sciences University, Portland, Ore (W.M.C)","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021508578","display_name":"M.J. Whitehouse","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1315135799","display_name":"Marshfield Clinic","ror":"https://ror.org/025chrz76","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315135799"]},{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I2801620527","display_name":"Mercy General Hospital","ror":"https://ror.org/04bt00m07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801620527","https://openalex.org/I2802827176"]},{"id":"https://openalex.org/I4210132091","display_name":"Electron Energy Corporation (United States)","ror":"https://ror.org/03v1rmf39","country_code":"US","type":"company","lineage":["https://openalex.org/I4210132091"]},{"id":"https://openalex.org/I4210138321","display_name":"Marshfield Clinic","ror":"https://ror.org/03zxy2q77","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210138321"]},{"id":"https://openalex.org/I4210158797","display_name":"CEP America","ror":"https://ror.org/04sygbn06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210158797"]},{"id":"https://openalex.org/I4405267392","display_name":"Kyverna Therapeutics, Inc. (United States)","ror":"https://ror.org/02jkbkr44","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267392"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. J. Whitehouse","raw_affiliation_strings":["From the Stanford Stroke Center, Palo Alto, Calif (G.W.A.); Oregon Health Sciences University, Portland, Ore (W.M.C); Mercy General Hospital, Sacramento, Calif (R.P.A.); Marshfield Clinic, Marchfield, Wis (K.M.); CoCensys, Irvine, Calif (J.L.D.); and Chiron Corporation, Emeryville, Calif (M.J.W.)","Chiron Corporation, Emeryville, Calif (M.J.W.)","CoCensys, Irvine, Calif (J.L.D.)","Marshfield Clinic, Marchfield, Wis (K.M.)","Mercy General Hospital, Sacramento, Calif (R.P.A.)","Oregon Health Sciences University, Portland, Ore (W.M.C)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Stanford Stroke Center, Palo Alto, Calif (G.W.A.); Oregon Health Sciences University, Portland, Ore (W.M.C); Mercy General Hospital, Sacramento, Calif (R.P.A.); Marshfield Clinic, Marchfield, Wis (K.M.); CoCensys, Irvine, Calif (J.L.D.); and Chiron Corporation, Emeryville, Calif (M.J.W.)","institution_ids":["https://openalex.org/I1315135799","https://openalex.org/I165690674","https://openalex.org/I2801620527","https://openalex.org/I4210138321"]},{"raw_affiliation_string":"Chiron Corporation, Emeryville, Calif (M.J.W.)","institution_ids":["https://openalex.org/I4210132091","https://openalex.org/I4210158797","https://openalex.org/I4405267392"]},{"raw_affiliation_string":"CoCensys, Irvine, Calif (J.L.D.)","institution_ids":[]},{"raw_affiliation_string":"Marshfield Clinic, Marchfield, Wis (K.M.)","institution_ids":["https://openalex.org/I1315135799"]},{"raw_affiliation_string":"Mercy General Hospital, Sacramento, Calif (R.P.A.)","institution_ids":["https://openalex.org/I2801620527"]},{"raw_affiliation_string":"Oregon Health Sciences University, Portland, Ore (W.M.C)","institution_ids":["https://openalex.org/I165690674"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.2908,"has_fulltext":false,"cited_by_count":86,"citation_normalized_percentile":{"value":0.93798794,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"30","issue":"3","first_page":"508","last_page":"513"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.888700008392334,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.888700008392334,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.10300000011920929,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nmda-receptor-antagonist","display_name":"NMDA receptor antagonists","score":0.9089999794960022},{"id":"https://openalex.org/keywords/glycine-site-antagonists","display_name":"glycine site antagonists","score":0.8309999704360962},{"id":"https://openalex.org/keywords/acute-ischemic-stroke","display_name":"acute ischemic stroke","score":0.9940000176429749},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.906000018119812},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.9490000009536743},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8050000071525574},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.8899999856948853},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.8479999899864197},{"id":"https://openalex.org/keywords/plasma-concentration","display_name":"plasma concentration","score":0.5270000100135803},{"id":"https://openalex.org/keywords/nihss","display_name":"NIHSS","score":0.847000002861023}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9563015699386597},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.6815183162689209},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.6129250526428223},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.6115344762802124},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5314734578132629},{"id":"https://openalex.org/C3020199598","wikidata":"https://www.wikidata.org/wiki/Q12202","display_name":"Ischemic stroke","level":3,"score":0.5289735198020935},{"id":"https://openalex.org/C3020166492","wikidata":"https://www.wikidata.org/wiki/Q12202","display_name":"Acute stroke","level":3,"score":0.480655312538147},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.4100794494152069},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3564888834953308},{"id":"https://openalex.org/C541997718","wikidata":"https://www.wikidata.org/wiki/Q188151","display_name":"Ischemia","level":2,"score":0.3420470356941223},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.32221394777297974},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.16017621755599976},{"id":"https://openalex.org/C2776572282","wikidata":"https://www.wikidata.org/wiki/Q416351","display_name":"Tissue plasminogen activator","level":2,"score":0.06893625855445862},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000208","descriptor_name":"Acute Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002545","descriptor_name":"Brain Ischemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011810","descriptor_name":"Quinoxalines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D018691","descriptor_name":"Excitatory Amino Acid Antagonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1161/01.str.30.3.508","doi":"https://doi.org/10.1161/01.str.30.3.508","is_oa":false,"landing_page_url":"https://doi.org/10.1161/01.str.30.3.508","pdf_url":null,"source":{"id":"https://openalex.org/S62532593","display_name":"Stroke","issn_l":"0039-2499","issn":["0039-2499","1524-4628"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Stroke","raw_type":"journal-article"},{"id":"pmid:10066844","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10066844","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Stroke","raw_type":"Clinical Trial"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.576.8495","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.576.8495","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://stroke.ahajournals.org/content/30/3/508.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W26082037","https://openalex.org/W52783869","https://openalex.org/W1981234599","https://openalex.org/W2001893348","https://openalex.org/W2003066583","https://openalex.org/W2015607927","https://openalex.org/W2042550512","https://openalex.org/W2048580896","https://openalex.org/W2062899329","https://openalex.org/W2079882374","https://openalex.org/W2279180182","https://openalex.org/W2983864680"],"related_works":["https://openalex.org/W2075615199","https://openalex.org/W7096398028","https://openalex.org/W2145840924","https://openalex.org/W2025606077","https://openalex.org/W7099933630","https://openalex.org/W2144407067","https://openalex.org/W2044546810","https://openalex.org/W2064655633","https://openalex.org/W2131673806","https://openalex.org/W2136796082"],"abstract_inverted_index":{"BACKGROUND":[0],"AND":[1],"PURPOSE:":[2],"Licostinel":[3,232],"(ACEA":[4],"1021;":[5],"5-nitro-6,":[6],"7-dichloro-2,3-quinoxalinedione),":[7],"a":[8,72,78,146,235],"competitive":[9],"antagonist":[10],"of":[11,26,31,42,62,71,75,98,110,121,137,148,174,194,216,244],"glycine":[12],"at":[13],"the":[14,37,95,167,205,209,245],"N-methyl-D-aspartate":[15],"(NMDA)":[16],"receptor,":[17],"is":[18,224],"an":[19,63],"effective":[20],"neuroprotective":[21,240],"agent":[22,241],"in":[23,44,184,191,203,218,228],"animal":[24,185],"models":[25],"cerebral":[27],"ischemia.":[28],"The":[29],"purpose":[30],"this":[32,51],"study":[33],"was":[34,92,201],"to":[35,124,140,221],"assess":[36],"safety,":[38],"tolerability,":[39],"and":[40,66,86,89,112,154,208,226,237],"pharmacokinetics":[41],"licostinel":[43,76,111,122,138,175,217],"patients":[45,56,104],"with":[46,68,84,94,107,130,145],"acute":[47,229],"stroke.":[48],"METHODS:":[49],"In":[50],"5-center":[52],"dose":[53,169],"escalation":[54],"trial,":[55],"were":[57,82,117,127,143,176],"enrolled":[58],"within":[59],"48":[60],"hours":[61],"ischemic":[64],"stroke":[65,186,230],"treated":[67,106],"ascending":[69],"doses":[70,109,120,136,219],"short":[73,214],"infusion":[74,215],"or":[77,161],"placebo.":[79],"Adverse":[80],"effects":[81,151,160],"assessed":[83],"clinical":[85],"laboratory":[87],"measurements,":[88],"patient":[90],"outcome":[91],"determined":[93],"National":[96,192],"Institutes":[97,193],"Health":[99,195],"Stroke":[100,196],"Scale.":[101],"RESULTS:":[102],"Sixty-four":[103],"(44":[105],"escalating":[108],"20":[113],"who":[114],"received":[115],"placebo)":[116],"treated.":[118],"Lower":[119],"(0.03":[123],"0.60":[125],"mg/kg)":[126,142],"not":[128],"associated":[129,144],"any":[131],"significant":[132,162],"adverse":[133,150],"effects.":[134],"Higher":[135],"(1.2":[139],"3.0":[141,222],"variety":[147],"mild-to-moderate":[149],"including":[152],"neurological":[153],"gastrointestinal":[155],"complaints.":[156],"No":[157],"major":[158],"psychotomimetic":[159],"safety":[163],"concerns":[164],"occurred.":[165],"At":[166],"higher":[168,178],"levels,":[170],"peak":[171],"plasma":[172],"concentrations":[173],"substantially":[177],"than":[179,242],"those":[180],"required":[181],"for":[182],"neuroprotection":[183],"models.":[187],"A":[188,213],"similar":[189],"improvement":[190],"Scale":[197],"scores":[198],"over":[199],"time":[200],"seen":[202],"both":[204],"placebo":[206],"group":[207],"licostinel-treated":[210],"patients.":[211,231],"CONCLUSIONS:":[212],"up":[220],"mg/kg":[223],"safe":[225],"tolerable":[227],"may":[233],"be":[234],"safer":[236],"better":[238],"tolerated":[239],"many":[243],"previously":[246],"evaluated":[247],"NMDA":[248],"antagonists.":[249]},"counts_by_year":[{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":4},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}